Details for New Drug Application (NDA): 202014
✉ Email this page to a colleague
NDA 202014 describes NORETHINDRONE, which is a drug marketed by Amneal Pharms, Glenmark Pharms Ltd, Lupin Ltd, Naari Pte Ltd, Novast Labs, Xiromed, Aurobindo Pharma Ltd, Barr, Barr Labs Inc, Dr Reddys Labs Sa, Apotex, Watson Labs, Watson Pharms Teva, Mylan Labs Ltd, Watson Labs Teva, and Teva Branded Pharm, and is included in sixty-three NDAs. It is available from nine suppliers. Additional details are available on the NORETHINDRONE profile page.
The generic ingredient in NORETHINDRONE is mestranol; norethindrone. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethindrone profile page.
The generic ingredient in NORETHINDRONE is mestranol; norethindrone. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethindrone profile page.
Summary for 202014
| Tradename: | NORETHINDRONE |
| Applicant: | Novast Labs |
| Ingredient: | norethindrone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202014
Suppliers and Packaging for NDA: 202014
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NORETHINDRONE | norethindrone | TABLET;ORAL-28 | 202014 | ANDA | Northstar Rx LLC | 16714-440 | 16714-440-01 | 1 BLISTER PACK in 1 PACKET (16714-440-01) / 1 KIT in 1 BLISTER PACK |
| NORETHINDRONE | norethindrone | TABLET;ORAL-28 | 202014 | ANDA | Northstar Rx LLC | 16714-440 | 16714-440-02 | 1 BLISTER PACK in 1 CARTON (16714-440-02) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.35MG | ||||
| Approval Date: | Sep 13, 2013 | TE: | AB1 | RLD: | No | ||||
Complete Access Available with Subscription
